If you think cholesterol-lowering statin drugs are an affront to your intelligence because they were approved on the false promise they save lives yet have only been proven to spare one non-mortal heart attack among 70 high-risk or one in 200 healthy adults over a 5-year period, then you will be just as outraged at the latest blockbuster drug Big Pharma just pulled out of its bags of tricks.
The drug, a monoclonal antibody called Ilaris (canakinumab), which is not new (first described in the...
Published on August 29, 2017 21:01